Stay updated on Niraparib Combo With TSR-042 in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Niraparib Combo With TSR-042 in Ovarian Cancer Clinical Trial page.

Latest updates to the Niraparib Combo With TSR-042 in Ovarian Cancer Clinical Trial page
- Check5 days agoChange DetectedStudy Record Dates show updated timestamps (e.g., Last Update Posted 2025-11-25 and 2025-11-10) with older entries removed. These are metadata updates and do not modify the study details, eligibility criteria, or outcomes.SummaryDifference0.1%

- Check12 days agoChange DetectedRevision: v3.3.2 replaces v3.2.0 on the page. This appears to be a maintenance update and does not modify the study details or content visible to users.SummaryDifference0.0%

- Check19 days agoChange DetectedNotice about government funding and operating status was removed; the remainder of the study details on the page remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check34 days agoChange DetectedThe page shows a minor update to the Study Record Dates with a new Last Update Posted timestamp; core study content such as design, eligibility, and locations remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check48 days agoChange DetectedUpdated location and date/status fields: replaced San Marcos, TX details with San Marcos, CA details and newer timestamps; older entries removed.SummaryDifference0.4%

- Check62 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference0.5%

Stay in the know with updates to Niraparib Combo With TSR-042 in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Niraparib Combo With TSR-042 in Ovarian Cancer Clinical Trial page.